Nanotechnology/Nanomedicines in Cancer Treatment

The application of nanotechnology to cancer treatment has some exciting potential consequences, including the possibility of eliminating cancerous tumours with little injury to healthy tissue and organs and the identification and removal of sick cells before they form tumours. Focused chemotherapy, which delivers a tumor-executing agent called tumour rot factor alpha (TNF) to developing tumours, is one form of treatment under investigation. TNF is attached to a gold nanoparticle together with Thiol-derivatized polyethylene glycol (PEG-THIOL), which hides the TNF-bearing nanoparticle from the resistant framework. This enables the nanoparticle to pass through the circulatory system unharmed.Delivering or Augmenting Radiotherapy.

  • Delivering Chemotherapy
  • Nano-enabled Immunotherapy

Related Conference of Nanotechnology/Nanomedicines in Cancer Treatment

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Nanotechnology/Nanomedicines in Cancer Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in